Wellgistics Health (NASDAQ:WGRX) Announces Quarterly Earnings Results

Wellgistics Health (NASDAQ:WGRX) released its quarterly earnings data on Tuesday. The company reported ($0.07) EPS for the quarter, FiscalAI reports. Wellgistics Health had a negative net margin of 433.95% and a negative return on equity of 1,617.25%. The business had revenue of $1.56 million during the quarter.

Wellgistics Health Stock Down 3.4%

Shares of WGRX stock opened at $0.17 on Wednesday. Wellgistics Health has a twelve month low of $0.07 and a twelve month high of $3.00. The stock has a market cap of $21.28 million, a P/E ratio of -0.12 and a beta of -1.17. The stock has a 50 day moving average of $0.12 and a 200 day moving average of $0.33. The company has a current ratio of 0.09, a quick ratio of 0.04 and a debt-to-equity ratio of 1.86.

Institutional Investors Weigh In On Wellgistics Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. XTX Topco Ltd lifted its stake in shares of Wellgistics Health by 195.1% in the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after purchasing an additional 70,137 shares during the period. Geode Capital Management LLC grew its position in Wellgistics Health by 81.0% during the fourth quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock valued at $195,000 after buying an additional 218,170 shares during the period. Heights Capital Management Inc. purchased a new position in Wellgistics Health in the third quarter valued at $2,588,000. Finally, Raymond James Financial Inc. increased its holdings in Wellgistics Health by 593.8% in the third quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock valued at $52,000 after buying an additional 50,000 shares in the last quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Wellgistics Health in a research report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

About Wellgistics Health

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.